Sinha travels to Verona
Alexis CFO joins the board at drug development company Verona.
Verona Pharma has appointed Vikas Sinha, the chief financial officer of Alexion Pharmaceuticals as a non-executive director.
David Ebsworth, chairman of Verona, said: “Vikas’ impressive financial background, including his US expertise, makes him a very welcome addition to our Board of Directors."
Sinha has banked 20 years' experience working in life sciences. Prior to Alexion, he worked for 11 years at Bayer AG where he held positions in the United States, Canada, Japan and Germany.
His last role was vice president and chief financial o
For thoughtful journalism, expert insights on corporate governance and an extensive library of reports, guides and tools to help boards and directors navigate the complexities of their roles, subscribe to Board Agenda
Related Stories
-
Olisa lined up for Interswitch; Whitman to leave Hewlett Packard Enterprise
Ken Olisa is set to lead African digital payments firm Interswitch, as it allegedly considers an IPO, while Meg Whitman is to leave HPE after six years.
-
Hampton joins Great Portland Estates
Food business finance chief to join property investors.
-
John Menzies delivers new senior non-exec
Aviation and distribution group reshuffles board
